Resistance-associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure.
Garcia-Cehic D, Rando A, Rodriguez-Frias F, Gregori J, Costa JG, Carrión JA, Macenlle R, Pamplona J, Castro-Iglesias A, Cañizares A, Tabernero D, Campos C, Buti M, Esteban JI, Quer J.
Garcia-Cehic D, et al. Among authors: tabernero d.
J Viral Hepat. 2021 Sep;28(9):1319-1324. doi: 10.1111/jvh.13497. Epub 2021 Mar 22.
J Viral Hepat. 2021.
PMID: 33720484